Inventor · disambiguated record
Peter Ulrichts
Also filed as: ULRICHTS PETER
10 granted patents·7 pending applications·128 citations·filing 2012–2025
90Inventor score
Top patents by PatentIndex Score
17 records- 0194US9765149B2Antibodies to CD70ARGEN-X N V·Filed 2014·Granted Sep 19, 2017·24 cites·22 claims
- 0294US9765148B2Antibodies to CD70SILENCE KAREN·Filed 2012·Granted Sep 19, 2017·32 cites·13 claims
- 0394US8834882B2Antibodies to CD70SILENCE KAREN·Filed 2013·Granted Sep 16, 2014·30 cites·12 claims
- 0492US11505585B2FcRn antagonists and methods of useargenx BV·Filed 2017·Granted Nov 22, 2022·7 cites·10 claims
- 0592US10316073B2FCRN antagonists and methods of useARGENX BVBA·Filed 2014·Granted Jun 11, 2019·20 cites·10 claims
- 0688US12240875B2Use of FCRN antagonists for treatment of generalized myasthenia gravisargenx BV·Filed 2018·Granted Mar 4, 2025·3 cites·21 claims
- 0785US12202900B2Compositions and methods for treating immune thrombocytopeniaargenx BV·Filed 2019·Granted Jan 21, 2025·4 cites·14 claims
- 0885US9926364B2Chimeric human-llama antigens and methods of useARGEN X N V·Filed 2012·Granted Mar 27, 2018·5 cites·18 claims
- 0983US11434298B2Antibodies to CD70argenx BV·Filed 2019·Granted Sep 6, 2022·1 cites·11 claims
- 1083US11072665B2Antibodies to CD70ARGENX BVBA·Filed 2015·Granted Jul 27, 2021·2 cites·39 claims
- 1181US2023265201A1Antibodies to cd70argenx BV·Filed 2022·Application pending·0 cites
- 1273US2025215090A1Compositions and methods for treating immune thrombocytopeniaargenx BV·Filed 2024·Application pending·0 cites
- 1370US2022275035A1Fcrn antagonists and methods of useargenx BV·Filed 2022·Application pending·0 cites
- 1461US2024325528A1Subcutaneous unit dosage formsargenx BV·Filed 2024·Application pending·0 cites
- 1560US2025179133A1Use of fcrn antagonists for treatment of generalized myasthenia gravisargenx BV·Filed 2025·Application pending·0 cites
- 1645US2016207996A1Antibodies to complex targetsARGEN X N V·Filed 2014·Application pending·0 cites
- 1736US2016264669A1Methods of reducing serum levels of fc-containing agents using fcrn antagonistsARGEN-X N V·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter Ulrichts files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →